nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprostadil—ABCC5—Fluorouracil—stomach cancer	0.243	0.383	CbGbCtD
Alprostadil—SLCO3A1—Methotrexate—stomach cancer	0.209	0.331	CbGbCtD
Alprostadil—ABCC4—Fluorouracil—stomach cancer	0.117	0.184	CbGbCtD
Alprostadil—ABCC4—Methotrexate—stomach cancer	0.0643	0.102	CbGbCtD
Alprostadil—PTGIR—blood vessel—stomach cancer	0.00557	0.0868	CbGeAlD
Alprostadil—PTGER1—pancreas—stomach cancer	0.00391	0.0609	CbGeAlD
Alprostadil—PTGER2—bone marrow—stomach cancer	0.00325	0.0506	CbGeAlD
Alprostadil—PTGIR—hematopoietic system—stomach cancer	0.00296	0.0462	CbGeAlD
Alprostadil—PTGER1—endocrine gland—stomach cancer	0.00276	0.043	CbGeAlD
Alprostadil—PTGIR—epithelium—stomach cancer	0.00271	0.0423	CbGeAlD
Alprostadil—PTGIR—smooth muscle tissue—stomach cancer	0.00261	0.0407	CbGeAlD
Alprostadil—PTGIR—pancreas—stomach cancer	0.00241	0.0376	CbGeAlD
Alprostadil—SLCO2A1—epithelium—stomach cancer	0.00237	0.0369	CbGeAlD
Alprostadil—SLCO2A1—pancreas—stomach cancer	0.00211	0.0329	CbGeAlD
Alprostadil—PTGIR—digestive system—stomach cancer	0.00206	0.0321	CbGeAlD
Alprostadil—PTGER2—lymph node—stomach cancer	0.00201	0.0314	CbGeAlD
Alprostadil—SLCO2B1—hematopoietic system—stomach cancer	0.00185	0.0289	CbGeAlD
Alprostadil—PTGIR—endocrine gland—stomach cancer	0.0017	0.0266	CbGeAlD
Alprostadil—ABCC4—hematopoietic system—stomach cancer	0.00164	0.0256	CbGeAlD
Alprostadil—PTGIR—liver—stomach cancer	0.00154	0.0239	CbGeAlD
Alprostadil—ABCC5—bone marrow—stomach cancer	0.00152	0.0237	CbGeAlD
Alprostadil—SLCO3A1—endocrine gland—stomach cancer	0.0015	0.0234	CbGeAlD
Alprostadil—SLCO2A1—endocrine gland—stomach cancer	0.00149	0.0232	CbGeAlD
Alprostadil—SLCO3A1—liver—stomach cancer	0.00136	0.0211	CbGeAlD
Alprostadil—SLCO2A1—liver—stomach cancer	0.00134	0.0209	CbGeAlD
Alprostadil—ABCC4—pancreas—stomach cancer	0.00134	0.0209	CbGeAlD
Alprostadil—SLCO2B1—digestive system—stomach cancer	0.00129	0.0201	CbGeAlD
Alprostadil—ABCC5—liver—stomach cancer	0.00123	0.0191	CbGeAlD
Alprostadil—PTGIR—lymph node—stomach cancer	0.00118	0.0184	CbGeAlD
Alprostadil—ABCC4—digestive system—stomach cancer	0.00114	0.0178	CbGeAlD
Alprostadil—SLCO2B1—endocrine gland—stomach cancer	0.00107	0.0166	CbGeAlD
Alprostadil—ABCC4—bone marrow—stomach cancer	0.00105	0.0164	CbGeAlD
Alprostadil—SLCO3A1—lymph node—stomach cancer	0.00104	0.0162	CbGeAlD
Alprostadil—SLCO2A1—lymph node—stomach cancer	0.00103	0.016	CbGeAlD
Alprostadil—SLCO2B1—liver—stomach cancer	0.000961	0.015	CbGeAlD
Alprostadil—ABCC4—endocrine gland—stomach cancer	0.000944	0.0147	CbGeAlD
Alprostadil—ABCC5—lymph node—stomach cancer	0.000941	0.0147	CbGeAlD
Alprostadil—ABCC4—liver—stomach cancer	0.000851	0.0133	CbGeAlD
Alprostadil—SLCO2B1—lymph node—stomach cancer	0.000737	0.0115	CbGeAlD
Alprostadil—ABCC4—lymph node—stomach cancer	0.000653	0.0102	CbGeAlD
Alprostadil—Lethargy—Epirubicin—stomach cancer	0.00025	0.00136	CcSEcCtD
Alprostadil—Cardiac failure congestive—Doxorubicin—stomach cancer	0.00025	0.00136	CcSEcCtD
Alprostadil—Hyperhidrosis—Irinotecan—stomach cancer	0.00025	0.00135	CcSEcCtD
Alprostadil—Pharyngitis—Docetaxel—stomach cancer	0.000249	0.00135	CcSEcCtD
Alprostadil—Bradycardia—Capecitabine—stomach cancer	0.000248	0.00134	CcSEcCtD
Alprostadil—Oedema—Fluorouracil—stomach cancer	0.000247	0.00134	CcSEcCtD
Alprostadil—Urethral disorder—Docetaxel—stomach cancer	0.000246	0.00134	CcSEcCtD
Alprostadil—Infection—Fluorouracil—stomach cancer	0.000246	0.00133	CcSEcCtD
Alprostadil—Pain in extremity—Epirubicin—stomach cancer	0.000245	0.00133	CcSEcCtD
Alprostadil—Haemoglobin—Capecitabine—stomach cancer	0.000244	0.00133	CcSEcCtD
Alprostadil—Rhinitis—Capecitabine—stomach cancer	0.000244	0.00132	CcSEcCtD
Alprostadil—Haemorrhage—Capecitabine—stomach cancer	0.000243	0.00132	CcSEcCtD
Alprostadil—Thrombocytopenia—Fluorouracil—stomach cancer	0.000242	0.00131	CcSEcCtD
Alprostadil—Visual impairment—Docetaxel—stomach cancer	0.000242	0.00131	CcSEcCtD
Alprostadil—Hypoaesthesia—Capecitabine—stomach cancer	0.000242	0.00131	CcSEcCtD
Alprostadil—Pharyngitis—Capecitabine—stomach cancer	0.000241	0.00131	CcSEcCtD
Alprostadil—Tachycardia—Fluorouracil—stomach cancer	0.000241	0.00131	CcSEcCtD
Alprostadil—Hypotension—Irinotecan—stomach cancer	0.000241	0.00131	CcSEcCtD
Alprostadil—Urethral disorder—Capecitabine—stomach cancer	0.000238	0.00129	CcSEcCtD
Alprostadil—Visual impairment—Capecitabine—stomach cancer	0.000234	0.00127	CcSEcCtD
Alprostadil—Flushing—Docetaxel—stomach cancer	0.000233	0.00127	CcSEcCtD
Alprostadil—Cardiac arrest—Epirubicin—stomach cancer	0.000233	0.00126	CcSEcCtD
Alprostadil—Hypoglycaemia—Doxorubicin—stomach cancer	0.000232	0.00126	CcSEcCtD
Alprostadil—Lethargy—Doxorubicin—stomach cancer	0.000231	0.00126	CcSEcCtD
Alprostadil—Hypotension—Fluorouracil—stomach cancer	0.000231	0.00125	CcSEcCtD
Alprostadil—Blood creatinine increased—Epirubicin—stomach cancer	0.000229	0.00125	CcSEcCtD
Alprostadil—Dyspepsia—Irinotecan—stomach cancer	0.000227	0.00123	CcSEcCtD
Alprostadil—Pain in extremity—Doxorubicin—stomach cancer	0.000227	0.00123	CcSEcCtD
Alprostadil—Flushing—Capecitabine—stomach cancer	0.000226	0.00123	CcSEcCtD
Alprostadil—Hypokalaemia—Epirubicin—stomach cancer	0.000223	0.00121	CcSEcCtD
Alprostadil—Pain—Irinotecan—stomach cancer	0.000221	0.0012	CcSEcCtD
Alprostadil—Erythema—Docetaxel—stomach cancer	0.000219	0.00119	CcSEcCtD
Alprostadil—Dyspepsia—Fluorouracil—stomach cancer	0.000218	0.00118	CcSEcCtD
Alprostadil—Cardiac arrest—Doxorubicin—stomach cancer	0.000216	0.00117	CcSEcCtD
Alprostadil—Feeling abnormal—Irinotecan—stomach cancer	0.000213	0.00115	CcSEcCtD
Alprostadil—Blood creatinine increased—Doxorubicin—stomach cancer	0.000212	0.00115	CcSEcCtD
Alprostadil—Erythema—Capecitabine—stomach cancer	0.000212	0.00115	CcSEcCtD
Alprostadil—Influenza—Epirubicin—stomach cancer	0.000212	0.00115	CcSEcCtD
Alprostadil—Back pain—Docetaxel—stomach cancer	0.000212	0.00115	CcSEcCtD
Alprostadil—Pain—Fluorouracil—stomach cancer	0.000211	0.00115	CcSEcCtD
Alprostadil—Muscle spasms—Docetaxel—stomach cancer	0.00021	0.00114	CcSEcCtD
Alprostadil—Upper respiratory tract infection—Methotrexate—stomach cancer	0.00021	0.00114	CcSEcCtD
Alprostadil—Hypokalaemia—Doxorubicin—stomach cancer	0.000206	0.00112	CcSEcCtD
Alprostadil—Back pain—Capecitabine—stomach cancer	0.000205	0.00111	CcSEcCtD
Alprostadil—Abdominal pain—Irinotecan—stomach cancer	0.000204	0.00111	CcSEcCtD
Alprostadil—Body temperature increased—Irinotecan—stomach cancer	0.000204	0.00111	CcSEcCtD
Alprostadil—Feeling abnormal—Fluorouracil—stomach cancer	0.000204	0.00111	CcSEcCtD
Alprostadil—Bronchitis—Epirubicin—stomach cancer	0.000204	0.00111	CcSEcCtD
Alprostadil—Muscle spasms—Capecitabine—stomach cancer	0.000204	0.0011	CcSEcCtD
Alprostadil—Anaemia—Docetaxel—stomach cancer	0.000202	0.0011	CcSEcCtD
Alprostadil—Renal failure—Methotrexate—stomach cancer	0.000198	0.00108	CcSEcCtD
Alprostadil—Upper respiratory tract infection—Epirubicin—stomach cancer	0.000197	0.00107	CcSEcCtD
Alprostadil—Syncope—Docetaxel—stomach cancer	0.000196	0.00106	CcSEcCtD
Alprostadil—Influenza—Doxorubicin—stomach cancer	0.000196	0.00106	CcSEcCtD
Alprostadil—Anaemia—Capecitabine—stomach cancer	0.000196	0.00106	CcSEcCtD
Alprostadil—Pollakiuria—Epirubicin—stomach cancer	0.000196	0.00106	CcSEcCtD
Alprostadil—Body temperature increased—Fluorouracil—stomach cancer	0.000195	0.00106	CcSEcCtD
Alprostadil—Haematuria—Methotrexate—stomach cancer	0.000192	0.00104	CcSEcCtD
Alprostadil—Loss of consciousness—Docetaxel—stomach cancer	0.000192	0.00104	CcSEcCtD
Alprostadil—Hyperglycaemia—Epirubicin—stomach cancer	0.000191	0.00104	CcSEcCtD
Alprostadil—Cough—Docetaxel—stomach cancer	0.000191	0.00104	CcSEcCtD
Alprostadil—Syncope—Capecitabine—stomach cancer	0.00019	0.00103	CcSEcCtD
Alprostadil—Convulsion—Docetaxel—stomach cancer	0.000189	0.00103	CcSEcCtD
Alprostadil—Hypertension—Docetaxel—stomach cancer	0.000189	0.00102	CcSEcCtD
Alprostadil—Bronchitis—Doxorubicin—stomach cancer	0.000188	0.00102	CcSEcCtD
Alprostadil—Loss of consciousness—Capecitabine—stomach cancer	0.000186	0.00101	CcSEcCtD
Alprostadil—Renal failure—Epirubicin—stomach cancer	0.000186	0.00101	CcSEcCtD
Alprostadil—Asthenia—Irinotecan—stomach cancer	0.000185	0.00101	CcSEcCtD
Alprostadil—Cough—Capecitabine—stomach cancer	0.000185	0.001	CcSEcCtD
Alprostadil—Urinary tract infection—Epirubicin—stomach cancer	0.000183	0.000996	CcSEcCtD
Alprostadil—Hypertension—Capecitabine—stomach cancer	0.000183	0.000992	CcSEcCtD
Alprostadil—Dry mouth—Docetaxel—stomach cancer	0.000182	0.000988	CcSEcCtD
Alprostadil—Upper respiratory tract infection—Doxorubicin—stomach cancer	0.000182	0.000988	CcSEcCtD
Alprostadil—Haemoglobin—Methotrexate—stomach cancer	0.000182	0.000988	CcSEcCtD
Alprostadil—Haemorrhage—Methotrexate—stomach cancer	0.000181	0.000983	CcSEcCtD
Alprostadil—Pollakiuria—Doxorubicin—stomach cancer	0.000181	0.000982	CcSEcCtD
Alprostadil—Haematuria—Epirubicin—stomach cancer	0.00018	0.000977	CcSEcCtD
Alprostadil—Pharyngitis—Methotrexate—stomach cancer	0.00018	0.000975	CcSEcCtD
Alprostadil—Oedema—Docetaxel—stomach cancer	0.000178	0.000969	CcSEcCtD
Alprostadil—Discomfort—Capecitabine—stomach cancer	0.000178	0.000967	CcSEcCtD
Alprostadil—Urethral disorder—Methotrexate—stomach cancer	0.000177	0.000963	CcSEcCtD
Alprostadil—Infection—Docetaxel—stomach cancer	0.000177	0.000962	CcSEcCtD
Alprostadil—Sinusitis—Epirubicin—stomach cancer	0.000177	0.000961	CcSEcCtD
Alprostadil—Hyperglycaemia—Doxorubicin—stomach cancer	0.000177	0.000959	CcSEcCtD
Alprostadil—Diarrhoea—Irinotecan—stomach cancer	0.000177	0.000959	CcSEcCtD
Alprostadil—Dry mouth—Capecitabine—stomach cancer	0.000176	0.000957	CcSEcCtD
Alprostadil—Shock—Docetaxel—stomach cancer	0.000176	0.000953	CcSEcCtD
Alprostadil—Pruritus—Fluorouracil—stomach cancer	0.000175	0.00095	CcSEcCtD
Alprostadil—Thrombocytopenia—Docetaxel—stomach cancer	0.000175	0.000949	CcSEcCtD
Alprostadil—Visual impairment—Methotrexate—stomach cancer	0.000174	0.000947	CcSEcCtD
Alprostadil—Tachycardia—Docetaxel—stomach cancer	0.000174	0.000945	CcSEcCtD
Alprostadil—Skin disorder—Docetaxel—stomach cancer	0.000173	0.000941	CcSEcCtD
Alprostadil—Oedema—Capecitabine—stomach cancer	0.000173	0.000938	CcSEcCtD
Alprostadil—Bradycardia—Epirubicin—stomach cancer	0.000173	0.000936	CcSEcCtD
Alprostadil—Renal failure—Doxorubicin—stomach cancer	0.000172	0.000932	CcSEcCtD
Alprostadil—Infection—Capecitabine—stomach cancer	0.000172	0.000932	CcSEcCtD
Alprostadil—Dizziness—Irinotecan—stomach cancer	0.000171	0.000927	CcSEcCtD
Alprostadil—Haemoglobin—Epirubicin—stomach cancer	0.00017	0.000924	CcSEcCtD
Alprostadil—Shock—Capecitabine—stomach cancer	0.00017	0.000923	CcSEcCtD
Alprostadil—Rhinitis—Epirubicin—stomach cancer	0.00017	0.000922	CcSEcCtD
Alprostadil—Urinary tract infection—Doxorubicin—stomach cancer	0.00017	0.000921	CcSEcCtD
Alprostadil—Haemorrhage—Epirubicin—stomach cancer	0.000169	0.00092	CcSEcCtD
Alprostadil—Diarrhoea—Fluorouracil—stomach cancer	0.000169	0.000918	CcSEcCtD
Alprostadil—Thrombocytopenia—Capecitabine—stomach cancer	0.000169	0.000918	CcSEcCtD
Alprostadil—Tachycardia—Capecitabine—stomach cancer	0.000169	0.000915	CcSEcCtD
Alprostadil—Hypoaesthesia—Epirubicin—stomach cancer	0.000169	0.000915	CcSEcCtD
Alprostadil—Pharyngitis—Epirubicin—stomach cancer	0.000168	0.000913	CcSEcCtD
Alprostadil—Skin disorder—Capecitabine—stomach cancer	0.000168	0.000911	CcSEcCtD
Alprostadil—Hyperhidrosis—Capecitabine—stomach cancer	0.000167	0.000907	CcSEcCtD
Alprostadil—Hypotension—Docetaxel—stomach cancer	0.000167	0.000905	CcSEcCtD
Alprostadil—Haematuria—Doxorubicin—stomach cancer	0.000167	0.000904	CcSEcCtD
Alprostadil—Urethral disorder—Epirubicin—stomach cancer	0.000166	0.000902	CcSEcCtD
Alprostadil—Sinusitis—Doxorubicin—stomach cancer	0.000164	0.000889	CcSEcCtD
Alprostadil—Dizziness—Fluorouracil—stomach cancer	0.000164	0.000888	CcSEcCtD
Alprostadil—Visual impairment—Epirubicin—stomach cancer	0.000163	0.000886	CcSEcCtD
Alprostadil—Rash—Irinotecan—stomach cancer	0.000163	0.000884	CcSEcCtD
Alprostadil—Dermatitis—Irinotecan—stomach cancer	0.000163	0.000883	CcSEcCtD
Alprostadil—Headache—Irinotecan—stomach cancer	0.000162	0.000878	CcSEcCtD
Alprostadil—Hypotension—Capecitabine—stomach cancer	0.000161	0.000876	CcSEcCtD
Alprostadil—Bradycardia—Doxorubicin—stomach cancer	0.00016	0.000866	CcSEcCtD
Alprostadil—Erythema—Methotrexate—stomach cancer	0.000158	0.000856	CcSEcCtD
Alprostadil—Haemoglobin—Doxorubicin—stomach cancer	0.000158	0.000855	CcSEcCtD
Alprostadil—Flushing—Epirubicin—stomach cancer	0.000157	0.000854	CcSEcCtD
Alprostadil—Rhinitis—Doxorubicin—stomach cancer	0.000157	0.000853	CcSEcCtD
Alprostadil—Dyspepsia—Docetaxel—stomach cancer	0.000157	0.000853	CcSEcCtD
Alprostadil—Haemorrhage—Doxorubicin—stomach cancer	0.000157	0.000851	CcSEcCtD
Alprostadil—Hypoaesthesia—Doxorubicin—stomach cancer	0.000156	0.000847	CcSEcCtD
Alprostadil—Rash—Fluorouracil—stomach cancer	0.000156	0.000846	CcSEcCtD
Alprostadil—Dermatitis—Fluorouracil—stomach cancer	0.000156	0.000846	CcSEcCtD
Alprostadil—Pharyngitis—Doxorubicin—stomach cancer	0.000156	0.000845	CcSEcCtD
Alprostadil—Headache—Fluorouracil—stomach cancer	0.000155	0.000841	CcSEcCtD
Alprostadil—Urethral disorder—Doxorubicin—stomach cancer	0.000154	0.000834	CcSEcCtD
Alprostadil—Nausea—Irinotecan—stomach cancer	0.000153	0.000832	CcSEcCtD
Alprostadil—Pain—Docetaxel—stomach cancer	0.000153	0.000828	CcSEcCtD
Alprostadil—Back pain—Methotrexate—stomach cancer	0.000152	0.000828	CcSEcCtD
Alprostadil—Dyspepsia—Capecitabine—stomach cancer	0.000152	0.000826	CcSEcCtD
Alprostadil—Visual impairment—Doxorubicin—stomach cancer	0.000151	0.00082	CcSEcCtD
Alprostadil—Pain—Capecitabine—stomach cancer	0.000148	0.000802	CcSEcCtD
Alprostadil—Erythema—Epirubicin—stomach cancer	0.000148	0.000801	CcSEcCtD
Alprostadil—Feeling abnormal—Docetaxel—stomach cancer	0.000147	0.000798	CcSEcCtD
Alprostadil—Nausea—Fluorouracil—stomach cancer	0.000147	0.000797	CcSEcCtD
Alprostadil—Anaemia—Methotrexate—stomach cancer	0.000146	0.000791	CcSEcCtD
Alprostadil—Flushing—Doxorubicin—stomach cancer	0.000146	0.00079	CcSEcCtD
Alprostadil—Nervousness—Epirubicin—stomach cancer	0.000143	0.000778	CcSEcCtD
Alprostadil—Back pain—Epirubicin—stomach cancer	0.000143	0.000774	CcSEcCtD
Alprostadil—Feeling abnormal—Capecitabine—stomach cancer	0.000142	0.000773	CcSEcCtD
Alprostadil—Muscle spasms—Epirubicin—stomach cancer	0.000142	0.00077	CcSEcCtD
Alprostadil—Abdominal pain—Docetaxel—stomach cancer	0.000141	0.000766	CcSEcCtD
Alprostadil—Body temperature increased—Docetaxel—stomach cancer	0.000141	0.000766	CcSEcCtD
Alprostadil—Cough—Methotrexate—stomach cancer	0.000138	0.000747	CcSEcCtD
Alprostadil—Abdominal pain—Capecitabine—stomach cancer	0.000137	0.000741	CcSEcCtD
Alprostadil—Body temperature increased—Capecitabine—stomach cancer	0.000137	0.000741	CcSEcCtD
Alprostadil—Convulsion—Methotrexate—stomach cancer	0.000137	0.000741	CcSEcCtD
Alprostadil—Erythema—Doxorubicin—stomach cancer	0.000136	0.000741	CcSEcCtD
Alprostadil—Anaemia—Epirubicin—stomach cancer	0.000136	0.00074	CcSEcCtD
Alprostadil—Discomfort—Methotrexate—stomach cancer	0.000133	0.00072	CcSEcCtD
Alprostadil—Nervousness—Doxorubicin—stomach cancer	0.000133	0.00072	CcSEcCtD
Alprostadil—Syncope—Epirubicin—stomach cancer	0.000132	0.000718	CcSEcCtD
Alprostadil—Back pain—Doxorubicin—stomach cancer	0.000132	0.000717	CcSEcCtD
Alprostadil—Muscle spasms—Doxorubicin—stomach cancer	0.000131	0.000712	CcSEcCtD
Alprostadil—Loss of consciousness—Epirubicin—stomach cancer	0.00013	0.000704	CcSEcCtD
Alprostadil—Cough—Epirubicin—stomach cancer	0.000129	0.000699	CcSEcCtD
Alprostadil—Asthenia—Docetaxel—stomach cancer	0.000128	0.000695	CcSEcCtD
Alprostadil—Convulsion—Epirubicin—stomach cancer	0.000128	0.000694	CcSEcCtD
Alprostadil—Infection—Methotrexate—stomach cancer	0.000128	0.000694	CcSEcCtD
Alprostadil—Hypertension—Epirubicin—stomach cancer	0.000127	0.000691	CcSEcCtD
Alprostadil—Pruritus—Docetaxel—stomach cancer	0.000126	0.000685	CcSEcCtD
Alprostadil—Anaemia—Doxorubicin—stomach cancer	0.000126	0.000685	CcSEcCtD
Alprostadil—Thrombocytopenia—Methotrexate—stomach cancer	0.000126	0.000684	CcSEcCtD
Alprostadil—Skin disorder—Methotrexate—stomach cancer	0.000125	0.000678	CcSEcCtD
Alprostadil—Hyperhidrosis—Methotrexate—stomach cancer	0.000124	0.000675	CcSEcCtD
Alprostadil—Discomfort—Epirubicin—stomach cancer	0.000124	0.000673	CcSEcCtD
Alprostadil—Asthenia—Capecitabine—stomach cancer	0.000124	0.000673	CcSEcCtD
Alprostadil—Dry mouth—Epirubicin—stomach cancer	0.000123	0.000667	CcSEcCtD
Alprostadil—Syncope—Doxorubicin—stomach cancer	0.000122	0.000664	CcSEcCtD
Alprostadil—Pruritus—Capecitabine—stomach cancer	0.000122	0.000664	CcSEcCtD
Alprostadil—Diarrhoea—Docetaxel—stomach cancer	0.000122	0.000663	CcSEcCtD
Alprostadil—Oedema—Epirubicin—stomach cancer	0.00012	0.000653	CcSEcCtD
Alprostadil—Hypotension—Methotrexate—stomach cancer	0.00012	0.000652	CcSEcCtD
Alprostadil—Loss of consciousness—Doxorubicin—stomach cancer	0.00012	0.000651	CcSEcCtD
Alprostadil—Infection—Epirubicin—stomach cancer	0.00012	0.000649	CcSEcCtD
Alprostadil—Cough—Doxorubicin—stomach cancer	0.000119	0.000646	CcSEcCtD
Alprostadil—Shock—Epirubicin—stomach cancer	0.000118	0.000643	CcSEcCtD
Alprostadil—Convulsion—Doxorubicin—stomach cancer	0.000118	0.000642	CcSEcCtD
Alprostadil—Diarrhoea—Capecitabine—stomach cancer	0.000118	0.000642	CcSEcCtD
Alprostadil—Dizziness—Docetaxel—stomach cancer	0.000118	0.000641	CcSEcCtD
Alprostadil—Thrombocytopenia—Epirubicin—stomach cancer	0.000118	0.00064	CcSEcCtD
Alprostadil—Hypertension—Doxorubicin—stomach cancer	0.000118	0.00064	CcSEcCtD
Alprostadil—Tachycardia—Epirubicin—stomach cancer	0.000117	0.000638	CcSEcCtD
Alprostadil—Skin disorder—Epirubicin—stomach cancer	0.000117	0.000635	CcSEcCtD
Alprostadil—Hyperhidrosis—Epirubicin—stomach cancer	0.000116	0.000632	CcSEcCtD
Alprostadil—Discomfort—Doxorubicin—stomach cancer	0.000115	0.000623	CcSEcCtD
Alprostadil—Dizziness—Capecitabine—stomach cancer	0.000114	0.00062	CcSEcCtD
Alprostadil—Dry mouth—Doxorubicin—stomach cancer	0.000114	0.000617	CcSEcCtD
Alprostadil—Dyspepsia—Methotrexate—stomach cancer	0.000113	0.000615	CcSEcCtD
Alprostadil—Rash—Docetaxel—stomach cancer	0.000113	0.000611	CcSEcCtD
Alprostadil—Hypotension—Epirubicin—stomach cancer	0.000112	0.000611	CcSEcCtD
Alprostadil—Dermatitis—Docetaxel—stomach cancer	0.000112	0.00061	CcSEcCtD
Alprostadil—Headache—Docetaxel—stomach cancer	0.000112	0.000607	CcSEcCtD
Alprostadil—Oedema—Doxorubicin—stomach cancer	0.000111	0.000605	CcSEcCtD
Alprostadil—Infection—Doxorubicin—stomach cancer	0.000111	0.000601	CcSEcCtD
Alprostadil—Pain—Methotrexate—stomach cancer	0.00011	0.000597	CcSEcCtD
Alprostadil—Shock—Doxorubicin—stomach cancer	0.00011	0.000595	CcSEcCtD
Alprostadil—Thrombocytopenia—Doxorubicin—stomach cancer	0.000109	0.000592	CcSEcCtD
Alprostadil—Rash—Capecitabine—stomach cancer	0.000109	0.000591	CcSEcCtD
Alprostadil—Dermatitis—Capecitabine—stomach cancer	0.000109	0.000591	CcSEcCtD
Alprostadil—Tachycardia—Doxorubicin—stomach cancer	0.000109	0.00059	CcSEcCtD
Alprostadil—Headache—Capecitabine—stomach cancer	0.000108	0.000588	CcSEcCtD
Alprostadil—Skin disorder—Doxorubicin—stomach cancer	0.000108	0.000587	CcSEcCtD
Alprostadil—Hyperhidrosis—Doxorubicin—stomach cancer	0.000108	0.000584	CcSEcCtD
Alprostadil—Nausea—Docetaxel—stomach cancer	0.000106	0.000575	CcSEcCtD
Alprostadil—Feeling abnormal—Methotrexate—stomach cancer	0.000106	0.000575	CcSEcCtD
Alprostadil—Dyspepsia—Epirubicin—stomach cancer	0.000106	0.000575	CcSEcCtD
Alprostadil—Hypotension—Doxorubicin—stomach cancer	0.000104	0.000565	CcSEcCtD
Alprostadil—Pain—Epirubicin—stomach cancer	0.000103	0.000559	CcSEcCtD
Alprostadil—Nausea—Capecitabine—stomach cancer	0.000103	0.000557	CcSEcCtD
Alprostadil—Body temperature increased—Methotrexate—stomach cancer	0.000102	0.000552	CcSEcCtD
Alprostadil—Abdominal pain—Methotrexate—stomach cancer	0.000102	0.000552	CcSEcCtD
Alprostadil—Feeling abnormal—Epirubicin—stomach cancer	9.92e-05	0.000538	CcSEcCtD
Alprostadil—Dyspepsia—Doxorubicin—stomach cancer	9.81e-05	0.000532	CcSEcCtD
Alprostadil—Pain—Doxorubicin—stomach cancer	9.53e-05	0.000517	CcSEcCtD
Alprostadil—Abdominal pain—Epirubicin—stomach cancer	9.52e-05	0.000517	CcSEcCtD
Alprostadil—Body temperature increased—Epirubicin—stomach cancer	9.52e-05	0.000517	CcSEcCtD
Alprostadil—Asthenia—Methotrexate—stomach cancer	9.23e-05	0.000501	CcSEcCtD
Alprostadil—Feeling abnormal—Doxorubicin—stomach cancer	9.18e-05	0.000498	CcSEcCtD
Alprostadil—Pruritus—Methotrexate—stomach cancer	9.1e-05	0.000494	CcSEcCtD
Alprostadil—Abdominal pain—Doxorubicin—stomach cancer	8.81e-05	0.000478	CcSEcCtD
Alprostadil—Body temperature increased—Doxorubicin—stomach cancer	8.81e-05	0.000478	CcSEcCtD
Alprostadil—Diarrhoea—Methotrexate—stomach cancer	8.8e-05	0.000478	CcSEcCtD
Alprostadil—Asthenia—Epirubicin—stomach cancer	8.64e-05	0.000469	CcSEcCtD
Alprostadil—Pruritus—Epirubicin—stomach cancer	8.52e-05	0.000462	CcSEcCtD
Alprostadil—Dizziness—Methotrexate—stomach cancer	8.51e-05	0.000462	CcSEcCtD
Alprostadil—Diarrhoea—Epirubicin—stomach cancer	8.24e-05	0.000447	CcSEcCtD
Alprostadil—Rash—Methotrexate—stomach cancer	8.11e-05	0.00044	CcSEcCtD
Alprostadil—Dermatitis—Methotrexate—stomach cancer	8.1e-05	0.00044	CcSEcCtD
Alprostadil—Headache—Methotrexate—stomach cancer	8.06e-05	0.000437	CcSEcCtD
Alprostadil—Asthenia—Doxorubicin—stomach cancer	7.99e-05	0.000434	CcSEcCtD
Alprostadil—Dizziness—Epirubicin—stomach cancer	7.96e-05	0.000432	CcSEcCtD
Alprostadil—Pruritus—Doxorubicin—stomach cancer	7.88e-05	0.000428	CcSEcCtD
Alprostadil—Nausea—Methotrexate—stomach cancer	7.64e-05	0.000415	CcSEcCtD
Alprostadil—Diarrhoea—Doxorubicin—stomach cancer	7.62e-05	0.000414	CcSEcCtD
Alprostadil—Rash—Epirubicin—stomach cancer	7.59e-05	0.000412	CcSEcCtD
Alprostadil—Dermatitis—Epirubicin—stomach cancer	7.58e-05	0.000412	CcSEcCtD
Alprostadil—Headache—Epirubicin—stomach cancer	7.54e-05	0.000409	CcSEcCtD
Alprostadil—Dizziness—Doxorubicin—stomach cancer	7.37e-05	0.0004	CcSEcCtD
Alprostadil—Nausea—Epirubicin—stomach cancer	7.15e-05	0.000388	CcSEcCtD
Alprostadil—Rash—Doxorubicin—stomach cancer	7.02e-05	0.000381	CcSEcCtD
Alprostadil—Dermatitis—Doxorubicin—stomach cancer	7.02e-05	0.000381	CcSEcCtD
Alprostadil—Headache—Doxorubicin—stomach cancer	6.98e-05	0.000379	CcSEcCtD
Alprostadil—Nausea—Doxorubicin—stomach cancer	6.62e-05	0.000359	CcSEcCtD
Alprostadil—ABCC5—Transmembrane transport of small molecules—APOA1—stomach cancer	5.24e-05	0.000443	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—IL6R—stomach cancer	5.07e-05	0.000428	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—FYN—stomach cancer	5.04e-05	0.000426	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—RHOA—stomach cancer	5.04e-05	0.000426	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—ADRB2—stomach cancer	4.92e-05	0.000415	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PPP2R1A—stomach cancer	4.82e-05	0.000407	CbGpPWpGaD
Alprostadil—ABCC5—Disease—RPS6—stomach cancer	4.81e-05	0.000406	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—HMOX1—stomach cancer	4.79e-05	0.000405	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—GSTT1—stomach cancer	4.74e-05	0.0004	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CD44—stomach cancer	4.7e-05	0.000397	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CYP2A6—stomach cancer	4.68e-05	0.000396	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—RHOA—stomach cancer	4.58e-05	0.000387	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—AKR1C3—stomach cancer	4.55e-05	0.000385	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—HSPB1—stomach cancer	4.55e-05	0.000385	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—AGTR2—stomach cancer	4.55e-05	0.000385	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—AGTR2—stomach cancer	4.55e-05	0.000385	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HSPB1—stomach cancer	4.55e-05	0.000385	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—BMP2—stomach cancer	4.5e-05	0.00038	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—F2R—stomach cancer	4.5e-05	0.00038	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—F2R—stomach cancer	4.5e-05	0.00038	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—BMP2—stomach cancer	4.5e-05	0.00038	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—SMAD4—stomach cancer	4.47e-05	0.000378	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—VEGFA—stomach cancer	4.44e-05	0.000375	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—ENO1—stomach cancer	4.44e-05	0.000375	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—AKR1C3—stomach cancer	4.43e-05	0.000374	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—AKR1C3—stomach cancer	4.43e-05	0.000374	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—CXCL8—stomach cancer	4.43e-05	0.000374	CbGpPWpGaD
Alprostadil—ABCC5—Disease—HBEGF—stomach cancer	4.42e-05	0.000373	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—HTR1A—stomach cancer	4.38e-05	0.00037	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HTR1A—stomach cancer	4.38e-05	0.00037	CbGpPWpGaD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—ALB—stomach cancer	4.34e-05	0.000367	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—PLAU—stomach cancer	4.3e-05	0.000364	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—FYN—stomach cancer	4.25e-05	0.000359	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—PRKCB—stomach cancer	4.24e-05	0.000358	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—PRKCB—stomach cancer	4.24e-05	0.000358	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—ANXA1—stomach cancer	4.23e-05	0.000358	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—ANXA1—stomach cancer	4.23e-05	0.000358	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—CAV1—stomach cancer	4.2e-05	0.000355	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—MAPK3—stomach cancer	4.2e-05	0.000355	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—APOA1—stomach cancer	4.2e-05	0.000354	CbGpPWpGaD
Alprostadil—ABCC5—Transmembrane transport of small molecules—ALB—stomach cancer	4.15e-05	0.000351	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—ADRB1—stomach cancer	4.1e-05	0.000346	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—ADRB1—stomach cancer	4.1e-05	0.000346	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—CXCL8—stomach cancer	4.02e-05	0.00034	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—PRKCB—stomach cancer	4e-05	0.000338	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—MAPK1—stomach cancer	4e-05	0.000338	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PPP2R1A—stomach cancer	4e-05	0.000338	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—FGFR2—stomach cancer	3.99e-05	0.000337	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CD44—stomach cancer	3.94e-05	0.000333	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—RPS6—stomach cancer	3.92e-05	0.000331	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—RPS6—stomach cancer	3.92e-05	0.000331	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—PRKCB—stomach cancer	3.85e-05	0.000326	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—PRKCB—stomach cancer	3.85e-05	0.000326	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—VEGFA—stomach cancer	3.84e-05	0.000325	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—IL6ST—stomach cancer	3.84e-05	0.000324	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—IL6ST—stomach cancer	3.84e-05	0.000324	CbGpPWpGaD
Alprostadil—ABCC5—Disease—SMAD4—stomach cancer	3.71e-05	0.000313	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IRS2—stomach cancer	3.65e-05	0.000308	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—MAPK3—stomach cancer	3.64e-05	0.000307	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—APOA1—stomach cancer	3.63e-05	0.000307	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HBEGF—stomach cancer	3.6e-05	0.000304	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—HBEGF—stomach cancer	3.6e-05	0.000304	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CAV1—stomach cancer	3.54e-05	0.000299	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—APOA1—stomach cancer	3.53e-05	0.000298	CbGpPWpGaD
Alprostadil—ABCC5—Disease—FYN—stomach cancer	3.52e-05	0.000298	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—stomach cancer	3.47e-05	0.000293	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—MAPK1—stomach cancer	3.46e-05	0.000292	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—IL6R—stomach cancer	3.42e-05	0.000289	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—IL6R—stomach cancer	3.42e-05	0.000289	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—RHOA—stomach cancer	3.41e-05	0.000288	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—RHOA—stomach cancer	3.41e-05	0.000288	CbGpPWpGaD
Alprostadil—ABCC5—Disease—ERCC2—stomach cancer	3.39e-05	0.000286	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PRKCB—stomach cancer	3.37e-05	0.000285	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IL6ST—stomach cancer	3.36e-05	0.000284	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PPP2R1A—stomach cancer	3.35e-05	0.000283	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—SERPINE1—stomach cancer	3.33e-05	0.000281	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—ALB—stomach cancer	3.32e-05	0.000281	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—ADRB2—stomach cancer	3.32e-05	0.000281	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—ADRB2—stomach cancer	3.32e-05	0.000281	CbGpPWpGaD
Alprostadil—ABCC5—Disease—FGFR2—stomach cancer	3.31e-05	0.000279	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—GSTP1—stomach cancer	3.28e-05	0.000277	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—KRAS—stomach cancer	3.27e-05	0.000276	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PPP2R1A—stomach cancer	3.25e-05	0.000275	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PPP2R1A—stomach cancer	3.25e-05	0.000275	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—HMOX1—stomach cancer	3.24e-05	0.000274	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—APC—stomach cancer	3.23e-05	0.000272	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—RHOA—stomach cancer	3.21e-05	0.000271	CbGpPWpGaD
Alprostadil—ABCC5—Disease—MTHFR—stomach cancer	3.18e-05	0.000269	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—NOS3—stomach cancer	3.18e-05	0.000269	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—RHOA—stomach cancer	3.09e-05	0.000261	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—RHOA—stomach cancer	3.09e-05	0.000261	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—MAPK3—stomach cancer	3.09e-05	0.000261	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—TYMS—stomach cancer	3.05e-05	0.000258	CbGpPWpGaD
Alprostadil—ABCC5—Disease—IRS2—stomach cancer	3.03e-05	0.000256	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—SMAD4—stomach cancer	3.02e-05	0.000255	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—SMAD4—stomach cancer	3.02e-05	0.000255	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—GSTM1—stomach cancer	3.02e-05	0.000255	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—PIK3CA—stomach cancer	3e-05	0.000254	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IL6R—stomach cancer	2.99e-05	0.000253	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—CXCL8—stomach cancer	2.99e-05	0.000253	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—CXCL8—stomach cancer	2.99e-05	0.000253	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—MAPK1—stomach cancer	2.94e-05	0.000248	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—EGFR—stomach cancer	2.94e-05	0.000248	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CAV1—stomach cancer	2.94e-05	0.000248	CbGpPWpGaD
Alprostadil—ABCC5—Disease—APOA1—stomach cancer	2.93e-05	0.000248	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—TP53—stomach cancer	2.9e-05	0.000245	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—ALB—stomach cancer	2.88e-05	0.000243	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—FYN—stomach cancer	2.87e-05	0.000242	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—FYN—stomach cancer	2.87e-05	0.000242	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—ERCC2—stomach cancer	2.84e-05	0.00024	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—PIK3CA—stomach cancer	2.81e-05	0.000237	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—SERPINE1—stomach cancer	2.8e-05	0.000237	CbGpPWpGaD
Alprostadil—ABCC5—Disease—IL6ST—stomach cancer	2.78e-05	0.000235	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—HRAS—stomach cancer	2.78e-05	0.000235	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—KRAS—stomach cancer	2.78e-05	0.000234	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CXCL8—stomach cancer	2.72e-05	0.000229	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CXCL8—stomach cancer	2.72e-05	0.000229	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—RHOA—stomach cancer	2.71e-05	0.000229	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—FGFR2—stomach cancer	2.69e-05	0.000228	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—FGFR2—stomach cancer	2.69e-05	0.000228	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—NOS3—stomach cancer	2.68e-05	0.000226	CbGpPWpGaD
Alprostadil—ABCC5—Disease—APC—stomach cancer	2.68e-05	0.000226	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—MTHFR—stomach cancer	2.67e-05	0.000225	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—PIK3CA—stomach cancer	2.55e-05	0.000215	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—ERBB2—stomach cancer	2.5e-05	0.000212	CbGpPWpGaD
Alprostadil—ABCC5—Disease—IL6R—stomach cancer	2.48e-05	0.00021	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IRS2—stomach cancer	2.47e-05	0.000208	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IRS2—stomach cancer	2.47e-05	0.000208	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CAV1—stomach cancer	2.46e-05	0.000208	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—APOA1—stomach cancer	2.45e-05	0.000207	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CAV1—stomach cancer	2.39e-05	0.000202	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CAV1—stomach cancer	2.39e-05	0.000202	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—APOA1—stomach cancer	2.39e-05	0.000202	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—APOA1—stomach cancer	2.39e-05	0.000202	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CXCL8—stomach cancer	2.37e-05	0.000201	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—HRAS—stomach cancer	2.36e-05	0.000199	CbGpPWpGaD
Alprostadil—ABCC5—Disease—SERPINE1—stomach cancer	2.33e-05	0.000196	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CDKN1B—stomach cancer	2.32e-05	0.000196	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—VEGFA—stomach cancer	2.29e-05	0.000193	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PRKCB—stomach cancer	2.28e-05	0.000192	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PRKCB—stomach cancer	2.28e-05	0.000192	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IL6ST—stomach cancer	2.27e-05	0.000192	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IL6ST—stomach cancer	2.27e-05	0.000192	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—IL6—stomach cancer	2.26e-05	0.000191	CbGpPWpGaD
Alprostadil—ABCC5—Disease—RHOA—stomach cancer	2.24e-05	0.00019	CbGpPWpGaD
Alprostadil—ABCC5—Disease—NOS3—stomach cancer	2.22e-05	0.000188	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CCND1—stomach cancer	2.21e-05	0.000187	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—JUN—stomach cancer	2.21e-05	0.000186	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—APC—stomach cancer	2.18e-05	0.000184	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—APC—stomach cancer	2.18e-05	0.000184	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—MAPK3—stomach cancer	2.17e-05	0.000183	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PPARG—stomach cancer	2.16e-05	0.000183	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MMP9—stomach cancer	2.15e-05	0.000181	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CDKN1A—stomach cancer	2.14e-05	0.000181	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MAPK8—stomach cancer	2.09e-05	0.000176	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—MAPK3—stomach cancer	2.09e-05	0.000176	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—MAPK3—stomach cancer	2.09e-05	0.000176	CbGpPWpGaD
Alprostadil—ABCC5—Disease—ERBB2—stomach cancer	2.08e-05	0.000175	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—MAPK1—stomach cancer	2.06e-05	0.000174	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PTGS2—stomach cancer	2.03e-05	0.000172	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IL6R—stomach cancer	2.02e-05	0.000171	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IL6R—stomach cancer	2.02e-05	0.000171	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—MAPK1—stomach cancer	1.99e-05	0.000168	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—MAPK1—stomach cancer	1.99e-05	0.000168	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—EGFR—stomach cancer	1.98e-05	0.000168	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—EGFR—stomach cancer	1.98e-05	0.000168	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—KRAS—stomach cancer	1.95e-05	0.000164	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—ALB—stomach cancer	1.94e-05	0.000164	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—VEGFA—stomach cancer	1.93e-05	0.000163	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CDKN1B—stomach cancer	1.92e-05	0.000162	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—STAT3—stomach cancer	1.91e-05	0.000161	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—PIK3CA—stomach cancer	1.9e-05	0.00016	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—PIK3CA—stomach cancer	1.9e-05	0.00016	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—SERPINE1—stomach cancer	1.89e-05	0.00016	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—SERPINE1—stomach cancer	1.89e-05	0.00016	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—KRAS—stomach cancer	1.87e-05	0.000158	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—KRAS—stomach cancer	1.87e-05	0.000158	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—NOS3—stomach cancer	1.86e-05	0.000157	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—RHOA—stomach cancer	1.83e-05	0.000154	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—RHOA—stomach cancer	1.83e-05	0.000154	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MAPK3—stomach cancer	1.82e-05	0.000154	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NOS3—stomach cancer	1.81e-05	0.000153	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NOS3—stomach cancer	1.81e-05	0.000153	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—PIK3CA—stomach cancer	1.79e-05	0.000151	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CDKN1A—stomach cancer	1.78e-05	0.00015	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MYC—stomach cancer	1.77e-05	0.00015	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MAPK1—stomach cancer	1.74e-05	0.000147	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—EGFR—stomach cancer	1.74e-05	0.000147	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—TP53—stomach cancer	1.73e-05	0.000146	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—PIK3CA—stomach cancer	1.72e-05	0.000146	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—PIK3CA—stomach cancer	1.72e-05	0.000146	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PTGS2—stomach cancer	1.7e-05	0.000144	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—ERBB2—stomach cancer	1.69e-05	0.000143	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—ERBB2—stomach cancer	1.69e-05	0.000143	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—HRAS—stomach cancer	1.66e-05	0.00014	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—KRAS—stomach cancer	1.64e-05	0.000139	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CXCL8—stomach cancer	1.6e-05	0.000136	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CXCL8—stomach cancer	1.6e-05	0.000136	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—HRAS—stomach cancer	1.59e-05	0.000135	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—HRAS—stomach cancer	1.59e-05	0.000135	CbGpPWpGaD
Alprostadil—ABCC5—Disease—STAT3—stomach cancer	1.58e-05	0.000134	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CDKN1B—stomach cancer	1.57e-05	0.000132	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CDKN1B—stomach cancer	1.57e-05	0.000132	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—IL6—stomach cancer	1.53e-05	0.000129	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—IL6—stomach cancer	1.53e-05	0.000129	CbGpPWpGaD
Alprostadil—ABCC5—Disease—MAPK3—stomach cancer	1.51e-05	0.000128	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PIK3CA—stomach cancer	1.51e-05	0.000127	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CCND1—stomach cancer	1.49e-05	0.000126	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CCND1—stomach cancer	1.49e-05	0.000126	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—JUN—stomach cancer	1.49e-05	0.000126	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—JUN—stomach cancer	1.49e-05	0.000126	CbGpPWpGaD
Alprostadil—ABCC5—Disease—MYC—stomach cancer	1.47e-05	0.000124	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—TP53—stomach cancer	1.46e-05	0.000123	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MMP9—stomach cancer	1.45e-05	0.000123	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MMP9—stomach cancer	1.45e-05	0.000123	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CDKN1A—stomach cancer	1.45e-05	0.000122	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CDKN1A—stomach cancer	1.45e-05	0.000122	CbGpPWpGaD
Alprostadil—ABCC5—Disease—MAPK1—stomach cancer	1.44e-05	0.000122	CbGpPWpGaD
Alprostadil—ABCC5—Disease—EGFR—stomach cancer	1.44e-05	0.000122	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MAPK8—stomach cancer	1.41e-05	0.000119	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MAPK8—stomach cancer	1.41e-05	0.000119	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—HRAS—stomach cancer	1.39e-05	0.000118	CbGpPWpGaD
Alprostadil—ABCC5—Disease—KRAS—stomach cancer	1.36e-05	0.000115	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IL6—stomach cancer	1.33e-05	0.000113	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—VEGFA—stomach cancer	1.3e-05	0.00011	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—VEGFA—stomach cancer	1.3e-05	0.00011	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—STAT3—stomach cancer	1.29e-05	0.000109	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—STAT3—stomach cancer	1.29e-05	0.000109	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PIK3CA—stomach cancer	1.25e-05	0.000106	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MAPK3—stomach cancer	1.23e-05	0.000104	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MAPK3—stomach cancer	1.23e-05	0.000104	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MYC—stomach cancer	1.2e-05	0.000101	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MYC—stomach cancer	1.2e-05	0.000101	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MAPK1—stomach cancer	1.17e-05	9.91e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MAPK1—stomach cancer	1.17e-05	9.91e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—EGFR—stomach cancer	1.17e-05	9.9e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—EGFR—stomach cancer	1.17e-05	9.9e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—HRAS—stomach cancer	1.16e-05	9.77e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—KRAS—stomach cancer	1.11e-05	9.36e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—KRAS—stomach cancer	1.11e-05	9.36e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—IL6—stomach cancer	1.11e-05	9.35e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PIK3CA—stomach cancer	1.05e-05	8.84e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PIK3CA—stomach cancer	1.02e-05	8.6e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PIK3CA—stomach cancer	1.02e-05	8.6e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—TP53—stomach cancer	9.84e-06	8.32e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TP53—stomach cancer	9.84e-06	8.32e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—HRAS—stomach cancer	9.41e-06	7.95e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HRAS—stomach cancer	9.41e-06	7.95e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IL6—stomach cancer	9.01e-06	7.61e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IL6—stomach cancer	9.01e-06	7.61e-05	CbGpPWpGaD
